Journal Article10.3357/ASEM.2903.2011
Various anti-motion sickness drugs and core body temperature changes.
22
TL;DR: The results suggest that the two most effective anti-motion sickness drugs are also the most effective in attenuating the rate of core temperature decrease.
read more
Abstract: Introduction Blood flow changes and inactivity associated with motion sickness appear to exacerbate the rate of core temperature decrease during subsequent body cooling. We investigated the effects of various classes of anti-motion sickness drugs on core temperature changes. Methods There were 12 healthy male and female subjects (20-35 yr old) who were given selected classes of anti-motion sickness drugs prior to vestibular Coriolis cross coupling induced by graded yaw rotation and periodic pitch-forward head movements in the sagittal plane. All subjects were then immersed in water at 18 degrees C for a maximum of 90 min or until their core temperature reached 35 degrees C. Double-blind randomized trials were administered, including a placebo, a non-immersion control with no drug, and six anti-motion sickness drugs: meclizine, dimenhydrinate, chlorpheniramine, promethazine + dexamphetamine, promethazine + caffeine, and scopolamine + dexamphetamine. A 7-d washout period was observed between trials. Core temperature and the severity of sickness were monitored throughout each trial. Results A repeated measures design was performed on the severity of sickness and core temperature changes prior to motion provocation, immediately after the motion sickness end point, and throughout the period of cold-water immersion. The most effective anti-motion sickness drugs, promethazine + dexamphetamine (with a sickness score/duration of 0.65 +/- 0.17) and scopolamine + dexamphetamine (with a sickness score/duration of 0.79 +/- 0.17), significantly attenuated the decrease in core temperature. The effect of this attenuation was lower in less effective drugs. Conclusion Our results suggest that the two most effective anti-motion sickness drugs are also the most effective in attenuating the rate of core temperature decrease.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Chapter 27 – Motion sickness
TL;DR: This chapter describes the signs and symptoms of motion sickness and different types of provocative stimuli, and the efficacy and relative advantages and disadvantages of various behavioral and pharmacologic countermeasures are evaluated.
106
Motion sickness, nausea and thermoregulation: The “toxic” hypothesis
Eugene Nalivaiko,John A. Rudd,Richard H. Y. So +2 more
- 31 Dec 2014
TL;DR: Evidence from human and animal experiments indicates that the physiological mechanisms responsible for the motion sickness-induced hypothermia include cutaneous vasodilation and sweating (leading to an increase of heat loss and reduced thermogenesis), which suggest that motion sickness triggers highly coordinated physiological response aiming to reduce body temperature.
81
Human Health during Space Travel: State-of-the-Art Review
Chayakrit Krittanawong,Nitin Kumar Singh,Richard A. Scheuring,Emmanuel Urquieta,Eric M. Bershad,Timothy R. Macaulay,Scott Kaplin,Carly J. Dunn,Stephen F Kry,Thais Russomano,M Shepanek,Raymond P. Stowe,Andrew W. Kirkpatrick,Timothy J. Broderick,Jean D. Sibonga,Andrew G. Lee,Brian Crucian +16 more
TL;DR: In this article , the authors synthesize developments across the continuum of space health including prior studies and unpublished data from NASA related to each individual organ system, and medical screening prior to space travel.
What is nausea? A historical analysis of changing views
Carey D. Balaban,Bill J. Yates +1 more
TL;DR: This review considers how the definition of "nausea" has evolved over time, and summarizes the physiological changes that occur prior to vomiting that may be indicative of nausea, as well as the accompanying physiological responses that occur with varying stimuli.
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.
Marieka V. DeVuono,Linda A. Parker +1 more
- 05 Jun 2020
TL;DR: Extended high doses of the main psychotropic compound in cannabis result in changes to the endocannabinoid system by acting on the cannabinoid 1 (CB1) receptor, which may cause Cannabinoid hyperemesis syndrome.
52